MergerLinks Header Logo

Announced

Completed

hC Bioscience completed the acquisition of 4SR Biosciences.

Synopsis

hC Bioscience, a company in the development of tRNA-based therapeutic, completed the acquisition of 4SR Biosciences, a University of Chicago startup focusing on tRNA diagnostics and therapeutics. Financial terms were not disclosed. “This deal consolidates proprietary discovery platforms, IP, and scientific expertise that will greatly advance our ability to discover and develop tRNA-based therapies. Bringing their powerful research tools and expertise in tRNA and structural biology in-house enables us to better understand fundamental mechanisms of tRNA biology and disease pathways associated with genetic errors and, importantly, how best to intervene with engineered tRNAs. We are excited for Drs Katanski and McGilvray to join us to advance tRNA as a therapeutic modality and for Dr. Pan, a leading authority and pioneer in the tRNA field, to join our Scientific Advisory Board,” Leslie Williams, hC Bioscience CEO.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US